Mr. Aldrich is a co-founder and Partner of Longwood Fund. He has co-founded and helped to build several successful biotech companies including Vertex Pharmaceuticals, Sirtris Pharmaceuticals (acquired by GlaxoSmithKline in 2008), Concert Pharmaceuticals (where he serves as Chairman of the Board), and Longwood portfolio companies Alnara Pharmaceuticals (acquired by Eli Lilly in 2010), Verastem, Flex Pharma, and Axial Biotherapeutics, where he is a Director. Mr. Aldrich also serves as a Director of Longwood portfolio companies Mitobridge, Inc., Renovia, Inc., and KalVista Pharmaceuticals. Prior to co-founding Longwood, Mr. Aldrich was General Partner of RA Capital, a life sciences hedge fund he co-founded in 2001 and in which he remains an investor. Mr. Aldrich was also a founding employee of Vertex Pharmaceuticals where he held the position of Senior Vice President and Chief Business Officer and managed all commercial and operating functions from 1989 to 2001. Prior to joining Vertex, Mr. Aldrich held several management positions at Biogen.
Mr. Aldrich earned his B.A. from Boston College and his M.B.A. from the Amos Tuck School at Dartmouth College.